查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197869

氧化應激測定市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Oxidative Stress Assay Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

氧化應激檢測市場預計在預測期內（2022 年至 2027 年）的複合年增長率為 9%。

在 COVID-19 期間，由於全球對研發活動的投資增加，預計氧化應激分析市場將會增長。 根據一篇題為“氧化應激和炎症過程對 SARS-CoV-2 發病機制的代謝影響”的論文。 根據 2021 年 5 月天然抗氧化劑的治療潛力，氧化應激和炎症通過乾擾多種信號通路在疾病進展和對治療的反應中發揮重要作用。據說這是一個相互交織的過程。 由於確保病毒結合和進入宿主細胞的構象變化所需的獨特條件，宿主細胞氧化還原狀態是病毒進入的關鍵因素。 這些研究證明了氧化應激分析在發現 COVID-19 的進展方面有多麼有用，並可能在未來幾年推動市場增長。

生物製藥和生物技術行業的快速增長以及慢性病的增加是預計將推動氧化應激分析市場增長的主要因素。 根據疾病控制與預防中心 (CDC) 2022 年 5 月更新，美國十分之六的成年人患有慢性病，十分之四的人患有兩種或多種疾病。 如此高的慢性病患病率增加了對氧化應激檢測的需求，因為慢性病會導致氧化劑和抗氧化水平失衡，從而提高結果的有效性和準確性。我是。

此外，為擴大氧化應激分析在各種疾病中的應用而進行的越來越多的研究也在推動市場增長。 例如，在 2021 年 9 月發表的文章“Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurpose Drug as an Anticancer Therapy”中，當濃度增加時，活性氧 (ROS) 反常地影響癌症的發展。據報導，中度高水平的 ROS 誘導腫瘤發生或支持癌細胞增殖，而高水平的 ROS 導致癌細胞死亡。 因此，活性氧可以被認為是癌症治療的有吸引力的目標。 此外，據報導，使用活性氧的回收藥物可能是克服當前癌症治療挑戰的有前途的方法之一。 此類研究和開發可能會導致新產品的開發和癌症診斷和治療應用的擴展，從而可能在不久的將來推動市場增長。

因此，由於上述因素，市場有望在預測期內實現增長。 然而，設備的高成本和缺乏訓練有素的人員來處理設備可能會阻礙市場增長。

氧化應激分析市場趨勢

在氧化應激分析市場，製藥和生物技術行業預計將佔據主要市場份額。

按最終用戶劃分，製藥和生物技術行業預計將佔據最大份額。 COVID-19 的突然爆發增加了對氧化應激分析的需求，因為它們在製藥和生物技術行業的研發中發揮著重要作用。 由於氧化應激分析廣泛用於產品開發過程，預計製藥和生物技術行業的研發投資激增將推動該領域的增長。 例如，根據經濟發展與合作組織（OECD）2021年公佈的數據，美國在醫藥和生物技術領域的研發投入強度跨過了3%的裡程碑，而中國則從2.1%上升到去年 2.2%。據報導。 另據報導，歐洲的研發支出增長率較為溫和，為 2.1%。

此外，監管機構的產品批准和新產品的發布也促進了這一細分市場的增長。 例如，2022年6月，AMSBIO將提供自由基（ROS和RNS）、非自由基活性衍生物（或氧化劑）、與抗氧化劑相關的抗體、生物標記物和檢測試劑盒的範圍擴大。

考慮到這些因素，由於在新疾病診斷的研發中採用了大量氧化應激分析產品，因此製藥和生物技術行業預計將佔據主要市場份額。

北美將佔據很大的市場份額，預計在預測期內也會如此

該地區生物製藥和生物技術公司的需求持續增長，預計將推動北美氧化應激分析市場的增長。 此外，越來越多地採用技術先進的設備和經驗豐富的專業人員的出現預計將推動該地區的市場增長。 生物製藥公司推出越來越多的新產品也促進了市場增長，因為氧化應激分析在生物製藥生產中發揮著重要作用。

此外，美國在生物技術領域加大研發投資也對該地區氧化應激分析市場的增長做出了重大貢獻。 例如，總部位於加州的安進公司在研發活動上投入巨資，2021 年、2020 年和 2019 年的研發支出分別為 48 億美元、42 億美元和 41 億美元。

此外，市場進入者的戰略舉措也在推動市場增長。 例如，2021 年 7 月，Immuchrom GmbH 與 Ilex Life Sciences 就胃腸道生物標誌物檢測在北美的商業化達成了合作協議。 Immuchrom 是一家德國公司，開發和製造 HPLC 應用、光度測定和免疫測定，專注於胃腸道疾病、心血管疾病、氧化應激、鈣和骨代謝領域。 這些努力也推動了市場的增長。

因此，考慮到所有這些因素，預計北美將佔據氧化應激市場的主要份額。

氧化應激檢測市場的競爭者分析

氧化應激分析市場是分散的，由幾個主要參與者組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 目前的市場壟斷企業包括 Abcam Plc、AMSBIO、Biovision Inc、Cell Biolabs, Inc、Enzo Life Sciences, Inc、Merck KGaA、Immunochemistry Technologies、Promega Corporation、Qiagen、Thermo Fisher Scientific 等。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 生物製藥和生物技術行業的快速增長
    • 增加研發投資
  • 市場製約因素
    • 設備成本高
    • 缺乏經驗豐富的人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 醫療設備
    • 消耗品
    • 服務
  • 按測試類型
    • 間接測量法
    • 抗氧化能力測定
    • □分析
    • 活性氧測量方法
  • 按技術
    • □聯免疫吸附試驗 (ELISA)
    • 流式細胞術
    • 色譜法
    • 顯微鏡
    • 其他
  • 按疾病類型
    • 心血管疾病
    • 慢性阻塞性肺疾病 (COPD)
    • 癌症
  • 最終用戶
    • 製藥和生物技術公司
    • 學術研究所
    • 臨床研究所
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Abcam PLC
    • AMSBIO
    • Biovision Inc
    • Cell Biolabs, Inc
    • Enzo life sciences, Inc
    • Merck KGaA
    • ImmunoChemistry Technologies
    • Promega Corporation
    • Qiagen
    • Thermo fisher scientific

第7章 市場機會與今後動向

簡介目錄
Product Code: 90455

The Oxidative Stress Assay Market is projected to register a CAGR of 9% during the forecast period (2022-2027).

Amidst COVID-19, the oxidative stress assay market is expected to grow due to the increasing investment in research and development activities across the globe. According to the article titled "Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants" published in May 2021, oxidative stress and inflammation are intertwined processes that play a vital role in disease progression and response to therapy via interference with multiple signaling pathways. The redox status of a host cell is an important factor in viral entry due to the unique conditions required for the conformational changes that ensure the binding and entry of a virus into the host cell. Such studies demonstrate how oxidative stress assays can be useful in finding COVID-19 progression and may propel the growth of the market over the coming years.

The rapid growth in the biopharmaceutical and biotechnology industries and the increase in chronic disorders are among the major factors expected to drive the growth of the oxidative stress assay market. According to the Center for Disease Control and Prevention (CDC) May 2022 update, six in ten adults in the United States have a chronic disease, and four in ten adults have two or more. Such a high prevalence of chronic diseases increased the demand for oxidative stress assays owing to the increased efficacy and precision of the results as chronic disorders result in an imbalance in oxidant and antioxidant levels.

Additionally, the increasing research studies to widen the application of the oxidative stress assay in different diseases is also propelling the growth of the market. For instance, the article titled "Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy" published in September 2021 reported that as concentrations increased, Reactive Oxygen Species (ROS) paradoxically influenced cancer development, either triggering tumorigenesis or supporting the proliferation of cancer cells at moderate levels of ROS or causing cancer cell death at high levels of ROS. Thus, ROS can be considered an attractive target for the therapy of cancer. It also reported that the use of ROS-based repurposed drugs may be one of the promising ways to overcome current cancer treatment challenges. Such research studies could lead to the development of new products and increasing applications in cancer diagnostics and therapeutics and hence may drive the growth of the market in the near future.

Therefore, due to the aforesaid factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and the lack of trained personnel to handle the equipment may hamper the market's growth.

Oxidative Stress Assay Market Trends

The Pharmaceutical and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Oxidative Stress Assay Market.

By end user, the pharmaceutical and biotechnology industries segment is anticipated to garner the largest share of the market. The sudden outbreak of COVID-19 has increased the demand for oxidative stress assays as these products play a major role in the research and development of the pharmaceutical and biotechnology industries. The surge in research and development investments in the pharmaceutical and biotechnology industries is expected to boost the segment's growth since oxidative stress assays are widely used in the product development process. For instance, the data published by the Organisation for Economic Development and Co-operation (OECD) in 2021 reported that research and development investment intensity in the pharmaceutical and biotechnology sectors in the United States surpassed the 3% milestone, while in China it was 2.1% to 2.2% from the past year. The report also stated that Europe experienced a more modest increase of 2.1 percent in research and development expenditure.

Additionally, the approval of products by the regulatory authorities and the launch of newer products are also contributing to the growth of the segment. For instance, in June 2022, AMSBIO expanded its range of antibodies, biomarkers, and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants), and antioxidants for researchers investigating the mechanism of oxidative stress.

Considering these factors, the pharmaceutical and biotechnology industry segment is expected to hold the major market share as they employ a significant number of oxidative stress assay products for the R&D of newer disease diagnoses.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The ever-increasing demand from biopharma and biotechnology companies in this region is expected to drive the growth of the oxidative stress assay market in North America. Moreover, the increase in the adoption of technologically advanced equipment and the presence of more experienced professionals is expected to propel the market growth in this region. Also, the increasing launches of new products by biopharma companies is a contributing factor to the growth of the market as oxidative stress assays play a crucial role in biopharmaceutical production.

Additionally, an upsurge in investment in research and development in the biotechnology sector in the United States is a major contributing factor to the growth of the oxidative stress assay market in this region. For instance, California-based Amgen Inc. invested heavily in its research and development activities and its expenditure for research and development was USD 4.8 billion, USD 4.2 billion, and USD 4.1 billion for 2021, 2020, and 2019, respectively.

Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in July 2021, ImmuchromGmbH signed a partnership agreement with Ilex Life Sciences for North American distribution of gastrointestinal biomarker assays. Immuchrom is a German developer and manufacturer of HPLC applications, photometric assays, and immunoassays, specializing in areas of gastrointestinal disease, the cardiovascular system, oxidative stress, and calcium and bone metabolism. Such initiatives are also boosting the growth of the market.

Thus, considering all these factors, North America is expected to hold a major share in the oxidative stress market.

Oxidative Stress Assay Market Competitor Analysis

The oxidative stress assay market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Abcam Plc, AMSBIO, Biovision Inc, Cell Biolabs, Inc, Enzo Life Sciences, Inc, Merck KGaA, Immunochemistry Technologies, Promega Corporation, Qiagen, Thermo Fisher Scientific, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Growth in Biopharmaceutical and Biotechnology Industries
    • 4.2.2 Increasing Investment in the Research and Development
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Equipment
    • 4.3.2 Lack of Experienced Personnel
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Test Type
    • 5.2.1 Indirect assays
    • 5.2.2 Antioxidant capacity assays
    • 5.2.3 Enzyme based assays
    • 5.2.4 Reactive Oxygen species based assays
  • 5.3 By Technology
    • 5.3.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 5.3.2 Flow Cytometry
    • 5.3.3 Chromatography
    • 5.3.4 Microscopy
    • 5.3.5 Others
  • 5.4 By Disease Type
    • 5.4.1 Cardiovascular disease
    • 5.4.2 Chronic Obstructive pulmonary disease (COPD)
    • 5.4.3 Cancer
  • 5.5 By End User
    • 5.5.1 Pharmaceutical and Biotechnology Industries
    • 5.5.2 Academic Research institutes
    • 5.5.3 Clinical Research Organizations
  • 5.6 Geography
    • 5.6.1 North America
      • 5.6.1.1 United States
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
    • 5.6.2 Europe
      • 5.6.2.1 Germany
      • 5.6.2.2 United Kingdom
      • 5.6.2.3 France
      • 5.6.2.4 Italy
      • 5.6.2.5 Spain
      • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
      • 5.6.3.1 China
      • 5.6.3.2 Japan
      • 5.6.3.3 India
      • 5.6.3.4 Australia
      • 5.6.3.5 South Korea
      • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East
      • 5.6.4.1 GCC
      • 5.6.4.2 South Africa
      • 5.6.4.3 Rest of Middle East
    • 5.6.5 South America
      • 5.6.5.1 Brazil
      • 5.6.5.2 Argentina
      • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abcam PLC
    • 6.1.2 AMSBIO
    • 6.1.3 Biovision Inc
    • 6.1.4 Cell Biolabs, Inc
    • 6.1.5 Enzo life sciences, Inc
    • 6.1.6 Merck KGaA
    • 6.1.7 ImmunoChemistry Technologies
    • 6.1.8 Promega Corporation
    • 6.1.9 Qiagen
    • 6.1.10 Thermo fisher scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS